This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
New Strong Buy Stocks for Oct. 14: HBM, GCT, and More
by Zacks Equity Research
HBM, GCT, WFRD, MMS and JXN have been added to the Zacks Rank #1 (Strong Buy) List on October 14, 2025.
Is Montrose Environmental Group (MEG) Stock Outpacing Its Business Services Peers This Year?
by Zacks Equity Research
Here is how Montrose Environmental (MEG) and Maximus (MMS) have performed compared to their sector so far this year.
Zacks.com featured highlights include Maximus, Pediatrix Medical, Sally Beauty and State Street
by Santanu Roy
Zacks highlights Maximus, Pediatrix Medical, Sally Beauty, and State Street as stocks trading near 52-week highs with potential for continued upside.
4 Stocks Trading Near 52-Week High With Room to Rise Further
by Vasundhara Sawalka
Investors target stocks that have been on a bullish run. Stocks like MMS, MD, SBH and STT are seeing price strength, and the momentum is likely to continue.
Here's Why You Should Retain Verisk Stock in Your Portfolio Now
by Zacks Equity Research
VRSK slips 7.6% this year, but AI-driven tools, fraud detection upgrades and steady shareholder returns fuel its long-term promise.
Zacks.com featured highlights include Universal Health Services, Methanex, Arista Networks, Voya Financial and Maximus
by Zacks Equity Research
Universal Health Services, Methanex, Arista Networks, Voya Financial and Maximus stand out for robust sales growth in a volatile market.
Reasons to Retain Trane Technologies Stock in Your Portfolio Now
by Zacks Equity Research
Trane Technologies advances AI-driven building solutions, boosts revenues and earnings outlook, and strengthens shareholder returns.
5 Stocks With Robust Sales Growth to Overcome Macro Challenges
by Swayta Shah
Arista, Voya, Universal Health, Methanex and Maximus show strong 2025 sales growth potential despite near-term challenges.
Here's Why Maximus Stock Is a Great Pick for Your Portfolio
by Zacks Equity Research
MMS shines with a 17.5% YTD stock surge, earnings growth prospects, CMMC Level 2 certification and steady dividends.
Is Experian (EXPGY) Stock Outpacing Its Business Services Peers This Year?
by Zacks Equity Research
Here is how Experian PLC (EXPGY) and Maximus (MMS) have performed compared to their sector so far this year.
Here's Why You Should Retain Fiserv Stock in Your Portfolio Now
by Zacks Equity Research
FI enhances its global presence through acquisitions, Clover expansion and key partnerships, driving strong growth despite market risks.
Here's Why TransUnion Stock Is a Great Pick Right Now
by Zacks Equity Research
TRU rallies 15.5% in six months, fueled by earnings beat, growth momentum and rising demand for its trusted communication solutions.
Here's Why Interpublic Group Stock Is a Great Pick At Present
by Zacks Equity Research
IPG shines with a 14.6% stock surge, AI-driven growth moves and steady dividends, making it a compelling buy now.
Reasons Why You Should Retain Rollins Stock in Your Portfolio Now
by Zacks Equity Research
ROL boosts revenues with strong demand, efficiency and acquisitions, but rising costs and weak liquidity weigh on margins.
Reasons to Retain Trane Technologies Stock in Your Portfolio Now
by Zacks Equity Research
TT climbs 19.7% with strong HVAC demand, AI-driven sustainability and rising earnings powering its growth momentum.
Reasons to Retain Charles River Stock in Your Portfolio for Now
by Zacks Equity Research
CRAI stock has surged 19.3% on strong Q2 results, rising dividends and share buybacks, even as liquidity pressures linger.
Is Futu Holdings (FUTU) Outperforming Other Business Services Stocks This Year?
by Zacks Equity Research
Here is how Futu Holdings Limited Sponsored ADR (FUTU) and Maximus (MMS) have performed compared to their sector so far this year.
Maximus (MMS) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
Maximus' Q3 Earnings Beat Estimates, Stock Rallies 4%
by Zacks Equity Research
MMS posts strong Q3 earnings and lifts 2025 guidance with higher revenues, profit and margin targets.
Is Maximus (MMS) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Maximus (MMS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Maximus (MMS) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Maximus (MMS) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Maximus (MMS) delivered earnings and revenue surprises of +55.40% and +4.48%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Gear Up for Maximus (MMS) Q3 Earnings: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Get a deeper insight into the potential performance of Maximus (MMS) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Geo Group (GEO) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Geo Group (GEO) delivered earnings and revenue surprises of +37.50% and +3.04%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Is Maximus (MMS) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.